Bioengineered magnetoferritin nanozymes for pathological identification of high-risk and ruptured atherosclerotic plaques in humans
Crossref DOI link: https://doi.org/10.1007/s12274-019-2313-z
Published Online: 2019-03-05
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Tao
He, Jiuyang
Duan, Demin
Jiang, Bing
Wang, Peixia
Fan, Kelong
Liang, Minmin
Yan, Xiyun
Text and Data Mining valid from 2019-03-05
Article History
Received: 7 December 2018
Revised: 23 January 2019
Accepted: 29 January 2019
First Online: 5 March 2019